METHOD FOR PREVENTING INSULIN RESISTANCE IN MALE PATIENTS DISTINGUISHED BY PARTIAL ANDROGEN AGE-SPECIFIC DEFICIENCY (PADAM)

FIELD: medicine. ^ SUBSTANCE: method involves reducing blood plasma level of growth somatotropic hormone, insulin-like growth factor-1, adrenocorticotropic hormone, hydrocortisone, insulin, glucose on the empty stomach. Pulsating secretion mode of growth somatotropic hormone, adrenocorticotropic hor...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MAZUROV V.I, KARPISHCHENKO A.I, PECHERSKIJ A.V, SEMIGLAZOV V.F, VELIKANOVA L.I
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	DIAGNOSIS HUMAN NECESSITIES HYGIENE IDENTIFICATION MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SURGERY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine. ^ SUBSTANCE: method involves reducing blood plasma level of growth somatotropic hormone, insulin-like growth factor-1, adrenocorticotropic hormone, hydrocortisone, insulin, glucose on the empty stomach. Pulsating secretion mode of growth somatotropic hormone, adrenocorticotropic hormone, hydrocortisone and insulin is recovered by individual selection of testosterone preparation dose providing normalized level of lutropin, general testosterone, free testosterone, globulin binding sex hormones, free androgen index, 5alpha-dihydrotestosterone, 17beta-estradiol, recovery of pulsating lutropin and general testosterone secretion. ^ EFFECT: enhanced effectiveness in acting upon pathogenic aspects of insulin resistance prophylaxis.